Paper3114530
Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
Nosoh Y and 7 others. Jpn J Surg, 1987. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice. Papers, record 3114530. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3114530
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Experimental studies on the combined effects of alpha and gamma interferons against human tumor xenografts transplanted into nude mice.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adenocarcinoma | Major topic |
| Breast Neoplasms | Major topic |
| Gallbladder Neoplasms | Major topic |
| Interferon Type I | Major topic |
| Interferon-gamma | Major topic |
| Mammary Neoplasms, Experimental | Major topic |
| Recombinant Proteins | Major topic |
| Stomach Neoplasms | Major topic |
| Animals | |
| Cell Line | |
| Drug Administration Schedule | |
| Drug Therapy, Combination | |
| Humans | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Neoplasm Transplantation |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6159047 | Does interferon cure cancer? | Br Med J | 1980 | https://conductscience.org/library/papers/6159047 | PubMed |
| 2 | 1203896 | Synergistic interaction of anticancer agents: a cellular perspective. | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1203896 | PubMed |
| 3 | 6175994 | Interferons: biochemical, cell growth inhibitory, and immunological effects. | Prog Hematol | 1981 | https://conductscience.org/library/papers/6175994 | PubMed |
| 4 | 6174218 | Potentiation of the direct anticellular activity of mouse interferons: mutual synergism and interferon concentration dependence. | Cancer Res | 1982 | https://conductscience.org/library/papers/6174218 | PubMed |
| 5 | 6195895 | Interferons with special emphasis on the immune system. | Adv Immunol | 1983 | https://conductscience.org/library/papers/6195895 | PubMed |
| 6 | 3932733 | In vitro chemosensitivity tests on human tumor xenografts by clonogenic assay: the combined use of mitomycin C with alpha-interferon or gamma-interferon. | Jpn J Surg | 1985 | https://conductscience.org/library/papers/3932733 | PubMed |
| 7 | 227796 | Potentiation of interferon activity by mixed preparations of fibroblast and immune interferon. | Infect Immun | 1979 | https://conductscience.org/library/papers/227796 | PubMed |
| 8 | 6180825 | Synergism in the antitumor effects of type 1 and type II interferon in mice inoculated with leukemia L1210 cells. | Cancer Lett | 1982 | https://conductscience.org/library/papers/6180825 | PubMed |
| 9 | 4561966 | Mechanism of the antitumour effect of interferon in mice. | Nature | 1972 | https://conductscience.org/library/papers/4561966 | PubMed |
| 10 | 6172715 | Evidence that types I and II interferons have different receptors. | Nature | 1981 | https://conductscience.org/library/papers/6172715 | PubMed |
| 11 | 6433798 | [Increased cytotoxic effects of various anticancer drugs by alpha-interferon (HLBI) on human tumor xenografts in nude mice]. | Gan To Kagaku Ryoho | 1984 | https://conductscience.org/library/papers/6433798 | PubMed |
| 12 | 5514991 | Antitumor effects of interferon preparations in mice. | J Natl Cancer Inst | 1970 | https://conductscience.org/library/papers/5514991 | PubMed |
| 13 | 6174742 | Clinical and immunologic effects of recombinant leukocyte A interferon in eight patients with advanced cancer. | JAMA | 1982 | https://conductscience.org/library/papers/6174742 | PubMed |
| 14 | 6329104 | [A cooperative phase I-II study of HLBI in patients with malignant tumors]. | Gan To Kagaku Ryoho | 1984 | https://conductscience.org/library/papers/6329104 | PubMed |
| 15 | 6319748 | Synergistic antiviral and antiproliferative activities of Escherichia coli-derived human alpha, beta, and gamma interferons. | J Virol | 1984 | https://conductscience.org/library/papers/6319748 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNG | 3458 | PubTator's text mining | https://conductscience.org/library/genes/3458 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3114530
GET https://conductscience.org/api/papers/v1/3114530/authors